References
Hutchins G, Southward K, Handley K, et al. Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol. 2011;29(10):1261–70.
Tran CG, Goffredo P, Mott SL, et al. Conditional survival after diagnosis of non-metastatic colon cancer: impact of laterality, MSI, and KRAS status. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14443-x.
Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–57.
Petrelli F, Tomasello G, Borgonovo K, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol. 2017;3(2):211–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Goffredo, P., Tran, C.G. & Hassan, I. ASO Author Reflections: Tailoring Surveillance to Tumor Biology: KRAS and Conditional Survival in Colon Cancer. Ann Surg Oncol 31, 1089–1090 (2024). https://doi.org/10.1245/s10434-023-14537-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14537-6